Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new pharmaceutical compounds like Sorafenib Tosylate and pembrolizumab. Notably, several previous entries related to locations and specific medical topics have been removed.
    Difference
    4%
    Check dated 2025-08-30T11:58:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-16T04:39:46.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:51:17.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T19:23:24.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-25T14:32:15.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-18T11:23:42.000Z thumbnail image

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.